
Presentation of the Institute
The Henri-Mondor University Cancer Institute (IUC) is the cancer center of the Henri-Mondor University Hospital Group (GHU), part of the Assistance Publique-Hôpitaux de Paris (AP-HP). It was created in partnership with the University of Paris-Est Créteil (UPEC) to coordinate cancer-related activities within the GHU. The IUC comprises two hospitals southeast of Paris.
Main Research Activities
The IUC translational and fundamental research is supported by the Mondor Institute for Biomedical Research (IMRB), Inserm-UPEC research unit, with 8 research teams active in the field of oncology. The IUC operates an early-phase center providing patients access to innovative treatments. Supported by the Clinical Research Unit and the Clinical Investigation Center, this clinical research enables patients to be enrolled in academic and industry-sponsored trials, across all disease stages.
Core Facilities
The IUC relies on a comprehensive range of medical and technical services with imaging (5 MRIs, 4 scanners), nuclear medicine, vectorized internal radiation therapy and laboratories with a genomic sequencing platform (2 HT sequencers). The IUC is also composed of a chemotherapy production unit with expertise in the field of reconstitution of IMP, and facilities for surgical treatment (21 operating rooms, 2 surgical robots), interventional radiology (3 rooms), endoscopy (3 rooms) and a department of radiation oncology (with 3 particle accelerators (1 with on-board MRI), 1 photobiomodulation device), among others. The IUC has facilities for supportive care with a dedicated platform, a readaptation unit and a Pain and Palliative Care Unit.
Education
The IUC professionals, in collaboration with UPEC, participate in training healthcare students, physicians, pharmacists, nurses and other caregivers. The IUC develops continuing education programs for professionals involved in cancer care and promotes interdisciplinary collaboration and knowledge sharing.